Bioenergetics in clinical medicine-X. Survey of the adjunctive use of coenzyme Q with oral therapy in treating periodontal disease.
Approximately 60% of young adults and 80% of middle-aged Americans have periodontal disease. Effective treatment of this widespread affliction is needed. It is generally believed that bacterial plaque on teeth and gingiva is the only direct cause of periodontal disease, and that control of plaque makes possible a normal periodontium in all age brackets. The fallacy in this common belief is the knowledge that effective oral physiotherapy can be ineffective in a small percentage of patients in periodontal practice. There is increasing knowledge and awareness that good nutrition is related to good periodontal health, and that many known vitamins influence the biochemistry of teeth, periodontium, and related bone.
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005881:Gingiva / Q000201:enzymology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010510:Periodontal Diseases / Q000188:drug therapy* / Q000201:enzymology; D010919:Placebos; D014451:Ubiquinone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use*
D010919:Placebos; D014451:Ubiquinone